It is interesting to note that a recent study [30] found mutations in the TGF-β and Wnt/β-catenin signaling pathways to be often associated with only a single cancer type (as opposed, for example, to mutations in proteins related to genome integrity, which tend to be associated with different cancer types). Here, TGFB1 is linked to cancer.